Clinical Trial Update: Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System

View source ↗

Summary

A completed clinical trial evaluated whether educational training via INSIGHT improves adherence to inhaled treprostinil (Ventavis) in patients with pulmonary a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Bayer | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED